| Product dosage: 0.5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.91 | $57.23 (0%) | 🛒 Add to cart |
| 60 | $1.81 | $114.46 $108.43 (5%) | 🛒 Add to cart |
| 90 | $1.77 | $171.69 $159.64 (7%) | 🛒 Add to cart |
| 120 | $1.76 | $228.92 $210.84 (8%) | 🛒 Add to cart |
| 180 | $1.74 | $343.37 $313.25 (9%) | 🛒 Add to cart |
| 270 | $1.73
Best per pill | $515.06 $465.86 (10%) | 🛒 Add to cart |
Similar products
More info:
Dutas: Advanced Treatment for Enlarged Prostate Relief
Dutas is a prescription medication containing the active ingredient dutasteride, designed to effectively manage and treat symptoms associated with benign prostatic hyperplasia (BPH). As a 5-alpha-reductase inhibitor, it works by reducing the production of dihydrotestosterone (DHT), a hormone that contributes to prostate growth. This targeted action helps alleviate urinary symptoms, improve flow, and reduce the risk of acute urinary retention and the need for prostate-related surgery. Dutas is intended for use in adult men and should be taken under medical supervision to ensure optimal outcomes and monitoring.
Avodart: Clinically Proven BPH Symptom Relief and Prostate Health
Avodart (dutasteride) is a prescription medication specifically formulated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. As a potent 5-alpha-reductase inhibitor, it works by fundamentally altering the hormonal pathway responsible for prostate growth, leading to a significant reduction in prostate volume. This action results in measurable improvements in urinary flow and a decrease in the bothersome symptoms associated with BPH, thereby enhancing quality of life.
Finpecia: Clinically Proven Hair Regrowth for Men
Finasteride, the active ingredient in Finpecia, is a well-established oral medication for the treatment of male pattern hair loss (androgenetic alopecia). It functions as a selective inhibitor of Type II 5-alpha-reductase, an enzyme responsible for converting testosterone into the more potent androgen, dihydrotestosterone (DHT). By significantly reducing serum and scalp DHT levels, Finpecia effectively halts the progression of hair loss and, in a majority of patients, stimulates the regrowth of miniaturized hairs.
Proscalpin: Clinically Proven Hair Regrowth Treatment
Proscalpin is a topical solution containing the active ingredient finasteride, specifically formulated to address androgenetic alopecia in men. This treatment works by inhibiting the conversion of testosterone to dihydrotestosterone (DHT), a key hormone implicated in pattern hair loss. With consistent application, Proscalpin has been demonstrated to promote hair regrowth, reduce further hair thinning, and stabilize the progression of male pattern baldness. It represents a scientifically-backed, non-invasive option for men seeking to restore their hair density and improve aesthetic outcomes.
Rogaine 5: Clinically Proven Hair Regrowth Treatment
Rogaine 5 (minoxidil topical solution 5%) is an FDA-approved topical treatment for androgenetic alopecia, commonly known as pattern hair loss. Its active ingredient, minoxidil, works by prolonging the anagen (growth) phase of the hair cycle, increasing blood flow to follicles, and stimulating dormant hair follicles. This formulation is specifically indicated for men and has demonstrated significant efficacy in clinical trials for vertex baldness and frontal thinning when used consistently as directed.
Abana: Natural Cardiovascular Support for Optimal Heart Health
Abana is a clinically studied, natural supplement formulated to support cardiovascular wellness and maintain healthy cholesterol levels already within the normal range. Developed through extensive research in Ayurvedic medicine, this proprietary blend combines potent botanicals and minerals known for their cardioprotective properties. Abana works holistically to promote circulatory function, support lipid metabolism, and provide antioxidant protection against oxidative stress. Its multi-mechanism approach makes it an ideal choice for individuals seeking comprehensive cardiovascular maintenance through evidence-based natural medicine.
Abhigra: Advanced Relief for Chronic Inflammatory Conditions
Abhigra represents a significant advancement in targeted anti-inflammatory therapy, engineered for patients with persistent inflammatory disorders who have found inadequate relief from conventional treatments. Developed through rigorous clinical research, this prescription medication employs a sophisticated mechanism of action to modulate inflammatory pathways at the cellular level, offering a new standard in both efficacy and tolerability. Its precision-targeted formulation minimizes systemic exposure while maximizing therapeutic impact at affected sites, making it a preferred option among rheumatologists, gastroenterologists, and dermatologists specializing in autoimmune and chronic inflammatory diseases.
Abilify: Atypical Antipsychotic for Symptom Control and Stability
Abilify (aripiprazole) is an atypical antipsychotic medication approved for the treatment of several psychiatric conditions, including schizophrenia, bipolar disorder, and as an adjunctive treatment for major depressive disorder. It functions as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and as an antagonist at serotonin 5-HT2A receptors, which contributes to its unique efficacy and tolerability profile. This mechanism helps stabilize dopamine and serotonin activity in the brain, reducing symptoms such as hallucinations, delusions, and mood swings while minimizing certain side effects commonly associated with first-generation antipsychotics.
Acamprol: Clinically Proven Relief for Alcohol Dependence
Acamprol (acamprosate calcium) is a prescription medication specifically developed to support maintenance of abstinence in alcohol-dependent patients. It functions by modulating neurotransmitter systems disrupted by chronic alcohol consumption, particularly glutamatergic hyperactivity, thereby reducing the psychological distress associated with alcohol withdrawal and craving. This pharmacological agent is indicated as part of a comprehensive management program that includes psychosocial support. Its delayed-release tablet formulation ensures consistent plasma concentrations, supporting long-term therapy adherence. Clinical trials and post-marketing surveillance have established its efficacy and safety profile in diverse patient populations.